Pharmacogenetics of antimalarial drugs: effect on metabolism and transport

R Kerb, R Fux, K Mörike, PG Kremsner… - The Lancet infectious …, 2009 - thelancet.com
The prevention and management of malaria is primarily based on the use of drugs. Clinical
trials have however revealed that between individuals there is large variability in the …

Human cytochrome P450 1, 2, 3 families as pharmacogenes with emphases on their antimalarial and antituberculosis drugs and prevalent African alleles

CR Chamboko, W Veldman, RB Tata… - International Journal of …, 2023 - mdpi.com
Precision medicine gives individuals tailored medical treatment, with the genotype
determining the therapeutic strategy, the appropriate dosage, and the likelihood of benefit or …

Antiparasitic chemotherapy: from genomes to mechanisms

D Horn, MT Duraisingh - Annual review of pharmacology and …, 2014 - annualreviews.org
Owing to the absence of antiparasitic vaccines and the constant threat of drug resistance,
the development of novel antiparasitic chemotherapies remains of major importance for …

Expanding the antimalarial drug arsenal—Now, but how?

BT Grimberg, RK Mehlotra - Pharmaceuticals, 2011 - mdpi.com
The number of available and effective antimalarial drugs is quickly dwindling. This is mainly
because a number of drug resistance-associated mutations in malaria parasite genes, such …

Effect of Single Nucleotide Polymorphisms in Cytochrome P450 Isoenzyme and N-Acetyltransferase 2 Genes on the Metabolism of Artemisinin-Based Combination …

EM Staehli Hodel, C Csajka, F Ariey… - Antimicrobial agents …, 2013 - Am Soc Microbiol
The pharmacogenetics of antimalarial agents are poorly known, although the application of
pharmacogenetics might be critical in optimizing treatment. This population pharmacokinetic …

Human Genetic Variation Is Associated With Plasmodium falciparum Drug Resistance

GM Paganotti, BC Gallo, F Verra… - Journal of Infectious …, 2011 - academic.oup.com
One approach to investigate if human genetic variation influences the selection of
Plasmodium falciparum drug resistance is to compare the frequency of resistant infections …

Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa

JL Baker, D Shriner, AR Bentley… - The pharmacogenomics …, 2017 - nature.com
As the common birthplace of all human populations, modern humans have lived longer on
the African continent than in any other geographical region of the world. This long history …

Pharmacological considerations in the design of anti-malarial drug combination therapies–is matching half-lives enough?

IM Hastings, EM Hodel - Malaria journal, 2014 - Springer
Anti-malarial drugs are now mainly deployed as combination therapy (CT), primarily as a
mechanism to prevent or slow the spread of resistance. This strategy is justified by …

Distribution of human CYP2C8*2 allele in three different African populations

GM Paganotti, S Gramolelli, F Tabacchi, G Russo… - Malaria journal, 2012 - Springer
Background The aim of this study was to investigate cytochrome P450 2C8* 2 (CYP2C8* 2)
distribution and allele frequency in three populations from West and East Africa exposed to …

[HTML][HTML] Can pharmacogenomics improve malaria drug policy?

MW Roederer, H McLeod… - Bulletin of the World …, 2011 - SciELO Public Health
Coordinated global efforts to prevent and control malaria have been a tour-de-force for
public health, but success appears to have reached a plateau in many parts of the world …